Crossmark

Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review

Crossref DOI link: https://doi.org/10.1007/s40123-023-00843-5

Published Online: 2023-12-06

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lowater, Simon Joel https://orcid.org/0000-0002-2882-5739
Grauslund, Jakob https://orcid.org/0000-0001-5019-0736
Subhi, Yousif https://orcid.org/0000-0001-6620-5365
Vergmann, Anna Stage https://orcid.org/0000-0003-0124-7542
License Information

Text and Data Mining valid from 2023-12-06

Version of Record valid from 2023-12-06
More Information

Article History

Received: 6 September 2023

Accepted: 20 October 2023

First Online: 6 December 2023